Our current research is focused on assessing small molecule inhibitors such as PI3K/mTOR inhibitors on their effectiveness in breast cancer cell growth using the estrogen receptor positive cell line models.
We also focus on determining the mechanism responsible of cyclohexanone derivatives responsible for their suppression of breast cancer cell growth.
In addition, we have several potential topoisomerase posions in our drug discovery program aimed at developing therapeutic strategies for breast cancer.
Collaborators:
A/Prof Rhonda Rosengren, Otago University
Dr. Lesley Larsen, New Zealand Institute for Crop and Food Research